Arch. Endocrinol. Metab. 2022;66(2):135-136
A new movie is about to premiere in nearby theaters. The way we see and treat obesity is bound to change
DOI: 10.20945/2359-3997000000466
“Pandemic”, “health crisis”, “global health threat”, “social and economic burden”. Obesity has been called by many different names. No matter what name you choose, obesity is still a growing issue, globally. Over the last five or six decades, the amount of individuals suffering from this condition has not ceased to increase.
Non-surgical treatment options are still scarce, and the outcomes are often disappointing. One of the main reasons for the frustrating panorama is our poor understanding of the underlying mechanisms of obesity. Only in the last 30 years or so science has begun to properly unravel the neuro-hormonal pathways that contribute to this disease. This knowledge is bringing new treatment options to the market, but the problem is still massive, not all patients have access to all therapeutic tools and the global prevalence remains growing.
[…]